Redeye remains optimistic about Insplorion’s prospects to establish the company as a provider of high-end sensors in the hydrogen market. Sales are still modest but commercial activities will pick up during 2025 following ATEX certification for the NPS-P2 sensor. We leave our forecasts unchanged. With a higher share price, leading to less dilution in future rights issues, our valuation is now a little higher.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/